Atlas Trials

Glitazones and Endothelial Function (GATE)

Clinical trial NCT00203632 · TERMINATED

Trial details

NCT number
NCT00203632
Sponsor
University of Calgary
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2003-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.